Clinical Trials Logo
  1. Home
  2. Intraabdominal Infections
  3. NCT01069900

Moxifloxacin in Pediatric Subjects With Complicated Intra-abdominal Infection — MOXIPEDIA  

Intraabdominal Infections Clinical Trial

Official title:
A Randomized, Double-blind, Multicenter Trial to Evaluate the Safety and Efficacy of Sequential (Intravenous, Oral) Moxifloxacin Versus Comparator in Pediatric Subjects With Complicated Intra-abdominal Infection

Clinical Trial Summary

The primary focus of the study is the evaluation of the safety of treatment with moxifloxacin in a pediatric population 3 months to <18 years old. Approximately 450 pediatric subjects with a complicated intra-abdominal infection will be enrolled in the study and treated with either moxifloxacin intravenously and orally if switched to oral therapy or ertapenem (intravenously) and, if switched to oral therapy, amoxicillin/clavulanate.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01069900
Study type Interventional
Source Bayer
Contact
Status Completed
Phase Phase 3
Start date July 21, 2010
Completion date January 21, 2015
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT03061500 - Prognostic Value of Proadrenomedullin in Intra-abdominal Sepsis N/A
Active, not recruiting NCT04612413 - A Phase 2 Study Evaluating Efficacy, Safety and Tolerability of Different Doses and Regimens of Allocetra-OTS for the Treatment of Organ Failure in Adult Sepsis Patients Phase 2
Completed NCT01763008 - A Study of the Safety and Effectiveness of Doripenem in Filipino Patients With Nosocomial Pneumonia, Complicated Intra-Abdominal Infections and Complicated Urinary Tract Infections Phase 4
Completed NCT03744741 - HostDx Sepsis in the Diagnosis and Prognosis of Emergency Department Patients With Suspected Infections: a Multicenter Pilot Study
Completed NCT02831556 - Point of Care 3D Ultrasound for Various Applications: A Pilot Study
Recruiting NCT03862378 - Prediction of Intra-abdominal Infectious Complication by Drainage Fluid Analysis
Recruiting NCT02979951 - Fosfomycin i.v. for Treatment of Severely Infected Patients
Withdrawn NCT04700787 - Safety, Tolerability, and Pharmacokinetics of Sulopenem in Adolescents Phase 1
Recruiting NCT03482245 - The Role of Circadian Clock Proteins in Innate and Adaptive Immunity N/A
Completed NCT03544203 - Multicentre Observational Study on Community Acquired Intraabdominal Infections Management